- Home
- GIGM vs SNTI Comparison
GIGM vs SNTI Comparison
Compare GIGM & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- SNTI
- Stock Information
- Founded
- GIGM 1998
- SNTI 2016
- Country
- GIGM Taiwan
- SNTI United States
- Employees
- GIGM N/A
- SNTI N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- GIGM Technology
- SNTI Health Care
- Exchange
- GIGM Nasdaq
- SNTI Nasdaq
- Market Cap
- GIGM 14.5M
- SNTI 14.1M
- IPO Year
- GIGM 2000
- SNTI N/A
- Fundamental
- Price
- GIGM $1.34
- SNTI $2.21
- Analyst Decision
- GIGM
- SNTI
- Analyst Count
- GIGM 0
- SNTI 0
- Target Price
- GIGM N/A
- SNTI N/A
- AVG Volume (30 Days)
- GIGM 12.1K
- SNTI 19.6K
- Earning Date
- GIGM 10-29-2024
- SNTI 11-11-2024
- Dividend Yield
- GIGM N/A
- SNTI N/A
- EPS Growth
- GIGM N/A
- SNTI N/A
- EPS
- GIGM N/A
- SNTI N/A
- Revenue
- GIGM $3,387,000.00
- SNTI $338,000.00
- Revenue This Year
- GIGM N/A
- SNTI $254.47
- Revenue Next Year
- GIGM N/A
- SNTI $169.66
- P/E Ratio
- GIGM N/A
- SNTI N/A
- Revenue Growth
- GIGM N/A
- SNTI N/A
- 52 Week Low
- GIGM $1.23
- SNTI $1.52
- 52 Week High
- GIGM $1.50
- SNTI $8.48
- Technical
- Relative Strength Index (RSI)
- GIGM 47.68
- SNTI 36.32
- Support Level
- GIGM $1.34
- SNTI $2.05
- Resistance Level
- GIGM $1.45
- SNTI $2.46
- Average True Range (ATR)
- GIGM 0.06
- SNTI 0.22
- MACD
- GIGM -0.00
- SNTI -0.08
- Stochastic Oscillator
- GIGM 23.53
- SNTI 12.90
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.